Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caryn Lerman

Showing results (181-190 of 283) with videos related to

Pageof 29
Sort By:
Behavioural Pharmacology|August 12, 2008
Dopamine and opioid gene variants are associated with increased smoking reward and reinforcement owing to negative moodKenneth A Perkins, Caryn Lerman, Amy Grottenthaler, et al.
Nuclear Medicine Communications|February 27, 2009
Dosimetry of 11C-carfentanil, a micro-opioid receptor imaging agentAndrew B Newberg, Riju Ray, Joshua Scheuermann, et al.
American Journal of Medical Genetics. Part A|January 6, 2005
BRCA1/2 testing in hereditary breast and ovarian cancer families II: impact on relationshipsAideen McInerney-Leo, Barbara Bowles Biesecker, Donald W Hadley, et al.
Biological Psychiatry|October 10, 2008
Varenicline improves mood and cognition during smoking abstinenceFreda Patterson, Christopher Jepson, Andrew A Strasser, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 12, 2014
Known and novel sources of variability in the nicotine metabolite ratio in a large sample of treatment-seeking smokersMeghan J Chenoweth, Maria Novalen, Larry W Hawk, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|March 4, 2015
Test-Retest Reliability and Stability of the Nicotine Metabolite Ratio Among Treatment-Seeking SmokersDiana A Hamilton, Martin C Mahoney, Maria Novalen, et al.
Clinical Pharmacology and Therapeutics|February 19, 2024
Genetic Prediction of Smoking Cessation Medication Side Effects: A Genome-Wide Investigation of Abnormal Dreams on VareniclineMeghan J Chenoweth, Yong Jae Kim, Nikki L Nollen, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|April 22, 2015
Initial Evaluation of Fenofibrate for Efficacy in Aiding Smoking AbstinenceKenneth A Perkins, Joshua L Karelitz, Valerie C Michael, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|June 13, 2015
The Nicotine Metabolite Ratio is Associated With Early Smoking Abstinence Even After Controlling for Factors That Influence the Nicotine Metabolite RatioMeghan J Chenoweth, Robert A Schnoll, Maria Novalen, et al.
American Journal of Medical Genetics. Part A|September 21, 2004
BRCA1/2 testing in hereditary breast and ovarian cancer families: effectiveness of problem-solving training as a counseling interventionAideen McInerney-Leo, Barbara Bowles Biesecker, Donald W Hadley, et al.
Pageof 29

Showing results (181-190 of 283) with videos related to

Sort By:
Pageof 29
Behavioural Pharmacology|August 12, 2008
Dopamine and opioid gene variants are associated with increased smoking reward and reinforcement owing to negative moodKenneth A Perkins, Caryn Lerman, Amy Grottenthaler, et al.
Nuclear Medicine Communications|February 27, 2009
Dosimetry of 11C-carfentanil, a micro-opioid receptor imaging agentAndrew B Newberg, Riju Ray, Joshua Scheuermann, et al.
American Journal of Medical Genetics. Part A|January 6, 2005
BRCA1/2 testing in hereditary breast and ovarian cancer families II: impact on relationshipsAideen McInerney-Leo, Barbara Bowles Biesecker, Donald W Hadley, et al.
Biological Psychiatry|October 10, 2008
Varenicline improves mood and cognition during smoking abstinenceFreda Patterson, Christopher Jepson, Andrew A Strasser, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 12, 2014
Known and novel sources of variability in the nicotine metabolite ratio in a large sample of treatment-seeking smokersMeghan J Chenoweth, Maria Novalen, Larry W Hawk, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|March 4, 2015
Test-Retest Reliability and Stability of the Nicotine Metabolite Ratio Among Treatment-Seeking SmokersDiana A Hamilton, Martin C Mahoney, Maria Novalen, et al.
Clinical Pharmacology and Therapeutics|February 19, 2024
Genetic Prediction of Smoking Cessation Medication Side Effects: A Genome-Wide Investigation of Abnormal Dreams on VareniclineMeghan J Chenoweth, Yong Jae Kim, Nikki L Nollen, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|April 22, 2015
Initial Evaluation of Fenofibrate for Efficacy in Aiding Smoking AbstinenceKenneth A Perkins, Joshua L Karelitz, Valerie C Michael, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|June 13, 2015
The Nicotine Metabolite Ratio is Associated With Early Smoking Abstinence Even After Controlling for Factors That Influence the Nicotine Metabolite RatioMeghan J Chenoweth, Robert A Schnoll, Maria Novalen, et al.
American Journal of Medical Genetics. Part A|September 21, 2004
BRCA1/2 testing in hereditary breast and ovarian cancer families: effectiveness of problem-solving training as a counseling interventionAideen McInerney-Leo, Barbara Bowles Biesecker, Donald W Hadley, et al.
Pageof 29